Screening for Chronic Liver Diseases in General Population

NARecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

October 9, 2024

Study Completion Date

January 1, 2029

Conditions
Fibrosis, Liver
Interventions
DIAGNOSTIC_TEST

Blood sample then fibroscan

"The patient takes a blood test if none less than 6 months old is available, including a complete blood count (CBC) and a hepatic check. The FIB-4 score will be calculated from this blood test.~If the result of the FIB-4 test is greater than 1.3 the person will be contacted by the SELHV (Service Expert de Lutte contre les Hépatites Virales) of the University Hospital of Montpellier in order to schedule, if she wishes, a second non-invasive screening examination of liver fibrosis by Fibroscan."

Trial Locations (1)

34295

RECRUITING

CHU de Montpellier, Montpellier

Sponsors
All Listed Sponsors
collaborator

On-call medical home (MMG) Clermont-Hérault

UNKNOWN

collaborator

Medical office Montpeyroux

UNKNOWN

collaborator

Medical office Clermont-Hérault

UNKNOWN

collaborator

Medical office Aniane

UNKNOWN

lead

University Hospital, Montpellier

OTHER